(1) Department of Gastroenterology, University Hospital Heraklion, P.O. Box 1352, 71110 Heraklion, Crete, Greece;(2) 1st Department of Gastroenterology, Evangelismos Hospital Athens, Athens, Greece
Abstract:
Background
Intravenous iron has been suggested as a safe and effective treatment of anemia complicating inflammatory bowel disease (IBD). Low molecular weight (LMW) iron dextran has the ability to administer the patient’s total iron requirement in a single infusion.